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Serotyping of invasive S. pneumoniae in adults,
more than ﬁfty years old, at a tertiary care
center
C. Wattal ∗, N. Goel, S. Byotra
Sir Ganga Ram Hospital, New Delhi, India
Background: The vast majority of the epidemiological data on
the pneumococcal disease is largely available in the pediatric pop-
ulation; however there is limited data in adults from India. In the
present study we evaluated antimicrobial susceptibilities testing
(AST) and serotypes of pneumococcal isolates in adult population.
Methods & Materials: The study was a hospital based prospec-
tive observational study. Fifty consecutive S. pneumoniae isolates
from patients ≥ 50 years with community acquired pneumococ-
cal infections from various sites (invasive and non invasive) were
included in the study. We performed antimicrobial susceptibil-
ity testing (AST) by disk diffusion and MIC testing by E-test and
serotyping by Quellung anti-capsular serotyping on these isolates.
Results: AST showed 100% sensitivity to penicillin, ceftriax-
one and vancomycin. Levoﬂoxacin, co-trimoxazole, erythromycin
and clindamycin showed sensitivity of 84%, 26%, 90% and 94%,
respectively. There swas low prevalence of multi-drug-resistant S.
pneumoniae (6%) observed in our study. Common serotypes iden-
tiﬁed were: 19A: (14%), 8: (10%), 19F: (8%); 3 and 9N: (6% each).
Non-vaccine serotypes (NVS) comprised 30% of the isolates with
no predominant serotypes. PCV7, PCV10, PCV13 and PCV23 vac-
cine coverage was observed as 16%, 24%, and 66% respectively. The
invasive serotypes comprised 38% of the total isolates and 42.1% of
these isolates were NVS.
Conclusion: Our study shows nil resistance of S. pneumoniae
to penicillin and a low prevalence of MDR. On the contrary there
was a high prevalence of resistance to co-trimoxazole and lev-
oﬂoxacin as compared to other asian countries. More importantly
our study showed emergence of 19A serotype as the predominant
serotype. There was also a poor coverage of currently available
PCV13 (24%) and PPV23 (66%) pneumococcal vaccines in adults,
and more importantly among invasive serotypes. In summary, our
ﬁndings show that the current vaccines recommended for adult
immunization program has modest efﬁcacy in Indian population,
especially in invasive infections. However PPV 23 vaccine appears
to be the best option as on today but Indian data may throw chal-
lenges for the PPV23 pneumococcal vaccine. Therefore, continuous
surveillance from different parts of India is needed for prudent use
of S. pneumoniae vaccination.
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Hospital Alemán, Buenos Aires, Argentina
Background: Since the ﬁrst renal transplantation performed
in Boston in 1954, solid organ transplantation became a common
strategyagainst end-stagediseases. TheGermanHospital inBuenos
Aires performed its ﬁrst renal transplantation in 2000 and since
then practice grew including also liver and heart transplantations.
After 15 years it is time to evaluate the current infectious compli-
cations, aiming to discover useful variables to work on.
Methods & Materials: This analysis is a retrospective observa-
tional study, for which we have reviewed the medical records of
all patients undergoing transplantation surgeries from 1-Jan-2014
to 31-Dec-2014. On an excel sheet we have analyzed information
such as: age, gender, underlying disease, type of immune suppres-
sion, time of onset of the infectious event and type and source of
microorganisms involved.
Results: Forty-six patients were transplanted during 2014, 33
(71.7%)of themhadat least one infectiousevent.Medianagewas55
(8-78, 70% between 31-65 years), 74% males. There was no differ-
ence between infected and not-infected regarding these 2 points.
Organs transplanted: 2 hearts, 21 kidneys and 23 livers. Percent-
age of infections was similar in the different groups. Twenty-seven
(33%) of infectious events were due to urinary tract infections, 19
of them in renal transplants (70%, p=0.02). CMV-reactivation was
seen in 12 cases, 9 (75%) of them in liver-transplantations. Primary
bacteremia was in third place (9, 13%) and surgical site infection in
fourth (7, 10%). Low numbers prevent from calculating rates. Most
of the infections (88%) showed up during the ﬁrst 3 months, only
1 (3%) after 6 months. There was a wide range of microorganisms
involved, 68% bacteria (70% GNB), 19% virus, 95 fungus and 4% TB.
Regarding the storage ﬂuid, 24% presented bacterial growth. There
wasn’t an increase incidence of infectious events in those in which
the storage ﬂuid was contaminated.
Conclusion: Urinary tract infection was the main complication
as literature mentions. Surgical site infections were not prevalent
in a particular group, which rules out inappropriate surgical tech-
nique. The variety of microorganisms involved rules out a common
source. CMVprophylaxis strategy in hepatic transplant patients has
to be reviewed.
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